Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Erythrocyte Parameters and Hypercoagulability in Sickle Cell Disease

NCT05376046 is registered in ClinicalTrials.gov with BILLOIR as lead sponsor.

NCT NCT05376046
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05376046 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Erythrocyte Parameters and Hypercoagulability in Sickle Cell Disease
Lead sponsor
BILLOIR
Phase
Observational
Overall status
Recruiting
Start date
September 1, 2018
Completion date
September 1, 2026
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease, vaso-occlusive crisis